Prescription Cost-Saving Platforms in Dermatology-Reference-Cited by-同舟云学术

Prescription Cost-Saving Platforms in Dermatology

Published:2024-09-11 Issue: Volume: Page:
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Ferreira Alana L.¹,Lipoff Jules B.²,Fabbro Stephanie K.³

Affiliation:

1. Perelman School of Medicine at the University of Pennsylvania, Philadelphia

2. Department of Dermatology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania

3. Division of Dermatology, OhioHealth Riverside Methodist Hospital, Columbus

Abstract

This Viewpoint discusses the pros and cons of cost-saving prescription drug platforms in dermatology.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2823477/jamadermatology_ferreira_2024_vp_240006_1725400025.32754.pdf

Reference8 articles.

1. Financial hardship from purchasing prescription drugs among older adults in the United States before, during, and after the Medicare Part D “donut hole”: findings from 1998, 2001, 2015, and 2021.;Olson;J Manag Care Spec Pharm,2022

2. An ethical analysis of pharmacy benefit manager (PBM) practices.;Drettwan;Pharmacy (Basel),2019

3. Comparison of discounted and undiscounted cash prices for cardiovascular medications by type of US community pharmacy.;Hong;J Gen Intern Med,2021

4. GoodRx. Home page. Accessed August 7, 2024. https://www.goodrx.com

5. Federal Trade Commission. FTC enforcement action to bar GoodRx from sharing consumers’ sensitive health info for advertising. February 1, 2023. Accessed August 7, 2024. https://www.ftc.gov/news-events/news/press-releases/2023/02/ftc-enforcement-action-bar-goodrx-sharing-consumers-sensitive-health-info-advertising